• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离甲状腺素水平及其他临床因素对裸金属支架再狭窄的影响。

Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis.

作者信息

Canpolat Uğur, Turak Osman, Özcan Fırat, Öksüz Fatih, Mendi Mehmet Ali, Yayla Çağrı, Aydoğdu Sinan

机构信息

Türkiye Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey.

出版信息

Arch Endocrinol Metab. 2017 Mar-Apr;61(2):130-136. doi: 10.1590/2359-3997000000197. Epub 2016 Aug 25.

DOI:10.1590/2359-3997000000197
PMID:28489156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10118861/
Abstract

OBJECTIVE

Thyroid hormones have both direct and indirect effects on thermogenesis such as modulating vascular smooth muscle cell proliferation. However, the influence of more subtle changes in thyroid hormones on coronary atherosclerosis remains a matter of speculation. Smooth muscle cells play a crucial role in the pathogenesis of in-stent restenosis (ISR). However, the relationship between free thyroxine (fT4) and ISR has not been studied. In the present study, we aimed to assess the role of preprocedural serum fT4 level on the development of ISR in patients undergoing coronary bare metal stent (BMS) implantation.

MATERIALS AND METHODS

We enrolled and analyzed clinical, biochemical, and angiographic data from 705 consecutive patients without a history of primary thyroid disease [mean age 60.3 ± 9.3 years, 505 (72%) male]; all patients had undergone BMS implantation and further control coronary angiography owing to stable or unstable angina pectoris. Patients were divided into 3 tertiles based on preprocedural serum fT4 levels.

RESULTS

ISR was observed in 53 (23%) patients in the lowest tertile, 82 (35%) patients in the second tertile, and 107 (46%) patients in the highest fT4 tertile (p < 0.001). Using multiple logistic regression analysis, five characteristics emerged as independent predictors of ISR: diabetes mellitus, smoking, HDL-cholesterol, stent length, and preprocedural serum fT4 level. In receiver operating characteristics curve analysis, fT4 level > 1.23 mg/dL had 70% sensitivity and 73% specificity (AUC: 0.75, p < 0.001) in predicting ISR.

CONCLUSION

Higher preprocedural serum fT4 is a powerful and independent predictor of BMS restenosis in patients with stable and unstable angina pectoris.

摘要

目的

甲状腺激素对产热具有直接和间接影响,比如调节血管平滑肌细胞增殖。然而,甲状腺激素更细微的变化对冠状动脉粥样硬化的影响仍存在争议。平滑肌细胞在支架内再狭窄(ISR)的发病机制中起关键作用。然而,游离甲状腺素(fT4)与ISR之间的关系尚未得到研究。在本研究中,我们旨在评估术前血清fT4水平在接受冠状动脉裸金属支架(BMS)植入的患者发生ISR中的作用。

材料与方法

我们纳入并分析了705例无原发性甲状腺疾病病史患者的临床、生化和血管造影数据[平均年龄60.3±9.3岁,505例(72%)为男性];所有患者因稳定型或不稳定型心绞痛接受了BMS植入及后续冠状动脉造影检查。根据术前血清fT4水平将患者分为三个三分位数组。

结果

在最低三分位数组中有53例(23%)患者发生ISR,第二三分位数组中有82例(35%)患者发生ISR,fT4最高三分位数组中有107例(46%)患者发生ISR(p<0.001)。通过多因素逻辑回归分析,出现了五个特征作为ISR的独立预测因素:糖尿病、吸烟、高密度脂蛋白胆固醇、支架长度和术前血清fT4水平。在受试者工作特征曲线分析中,fT4水平>1.23mg/dL在预测ISR时具有70%的敏感性和73%的特异性(曲线下面积:0.75,p<0.001)。

结论

术前血清fT4水平较高是稳定型和不稳定型心绞痛患者BMS再狭窄的有力且独立的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/0b8526757a3a/2359-4292-aem-61-02-0130-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/dcd83d48999e/2359-4292-aem-61-02-0130-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/3608d93fe1c1/2359-4292-aem-61-02-0130-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/0b8526757a3a/2359-4292-aem-61-02-0130-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/dcd83d48999e/2359-4292-aem-61-02-0130-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/3608d93fe1c1/2359-4292-aem-61-02-0130-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f878/10118861/0b8526757a3a/2359-4292-aem-61-02-0130-gf03.jpg

相似文献

1
Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis.游离甲状腺素水平及其他临床因素对裸金属支架再狭窄的影响。
Arch Endocrinol Metab. 2017 Mar-Apr;61(2):130-136. doi: 10.1590/2359-3997000000197. Epub 2016 Aug 25.
2
Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.术前血清尿酸水平对预测裸金属支架再狭窄的价值。
Am J Cardiol. 2014 Jan 15;113(2):197-202. doi: 10.1016/j.amjcard.2013.09.004. Epub 2013 Oct 2.
3
Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.中性粒细胞与淋巴细胞比值预测金属裸支架再狭窄的价值。
Am J Cardiol. 2012 Nov 15;110(10):1405-10. doi: 10.1016/j.amjcard.2012.07.003. Epub 2012 Aug 2.
4
Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.血小板与淋巴细胞比值在预测裸金属支架再狭窄中的应用价值。
Scand Cardiovasc J. 2015 Feb;49(1):39-44. doi: 10.3109/14017431.2014.989537. Epub 2014 Dec 26.
5
Preprocedural red blood cell distribution width predicts bare metal stent restenosis.术前红细胞分布宽度可预测裸金属支架再狭窄。
Coron Artery Dis. 2014 Sep;25(6):469-73. doi: 10.1097/MCA.0000000000000105.
6
A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.比较裸金属支架和药物洗脱支架的支架内再狭窄的临床表现、血管造影模式和结局。
EuroIntervention. 2010 Feb;5(7):841-6. doi: 10.4244/eijv5i7a141.
7
A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.裸金属支架再狭窄的一个潜在标志物:单核细胞计数与高密度脂蛋白胆固醇比值。
BMC Cardiovasc Disord. 2016 Oct 3;16(1):186. doi: 10.1186/s12872-016-0367-3.
8
Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.急性冠状动脉综合征 - 金属裸支架再狭窄的常见临床表现。
Kardiol Pol. 2010 Jun;68(6):637-45.
9
Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.红细胞分布宽度在预测稳定性心绞痛患者冠状动脉支架置入术后药物洗脱支架再狭窄中的作用
Coron Artery Dis. 2015 May;26(3):220-4. doi: 10.1097/MCA.0000000000000221.
10
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.二代药物洗脱支架置入术后三血管病变患者血运重建和支架内再狭窄的危险因素:回顾性分析。
BMC Cardiovasc Disord. 2021 Sep 17;21(1):446. doi: 10.1186/s12872-021-02259-0.

引用本文的文献

1
Analysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis after Revascularization.冠状动脉支架再狭窄患者血管重建术后主要不良心血管事件的危险因素分析
Rev Cardiovasc Med. 2023 May 18;24(5):146. doi: 10.31083/j.rcm2405146. eCollection 2023 May.
2
Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease.冠心病患者冠状动脉药物洗脱支架初次植入后支架内再狭窄的风险调查
Front Cardiovasc Med. 2023 Mar 10;10:1117915. doi: 10.3389/fcvm.2023.1117915. eCollection 2023.
3
Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis.

本文引用的文献

1
Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis.吸烟与冠状动脉支架置入术后再狭窄及主要不良心脏事件的关联:一项荟萃分析。
Pak J Med Sci. 2015 Jul-Aug;31(4):1002-8. doi: 10.12669/pjms.314.7495.
2
The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation.甲状腺激素三碘甲状腺原氨酸控制巨噬细胞的成熟和功能:在炎症期间的保护作用。
Am J Pathol. 2014 Jan;184(1):230-47. doi: 10.1016/j.ajpath.2013.10.006. Epub 2013 Nov 8.
3
Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents.
与早发性症状性颅内动脉粥样硬化相关的分子生物标志物
Clin Interv Aging. 2021 Jun 1;16:1013-1022. doi: 10.2147/CIA.S309945. eCollection 2021.
4
Early Restenosis of Sirolimus-eluting Stent: An Unusual Case of a Hyperthyroid Patient.西罗莫司洗脱支架的早期再狭窄:一例甲状腺功能亢进患者的罕见病例。
Cureus. 2019 Dec 28;11(12):e6490. doi: 10.7759/cureus.6490.
裸金属支架植入术后再狭窄独立危险因素的识别:裸金属支架在药物洗脱支架时代的作用。
Exp Ther Med. 2013 Sep;6(3):840-846. doi: 10.3892/etm.2013.1212. Epub 2013 Jul 10.
4
Comparison of restenosis rate with sirolimus-eluting stent in STEMI patients with and without diabetes at 6-month angiographic follow-up.
Acta Cardiol. 2011 Oct;66(5):603-6. doi: 10.1080/ac.66.5.2131085.
5
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.血管炎症与修复:对再内皮化、再狭窄和支架内血栓形成的影响。
JACC Cardiovasc Interv. 2011 Oct;4(10):1057-66. doi: 10.1016/j.jcin.2011.05.025.
6
Restenosis after PCI. Part 2: prevention and therapy.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 2 部分:预防和治疗。
Nat Rev Cardiol. 2011 Oct 11;9(2):79-90. doi: 10.1038/nrcardio.2011.148.
7
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
8
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.糖尿病患者的冠状动脉疾病血运重建:经皮冠状动脉介入治疗、支架和冠状动脉旁路移植术。
Rev Endocr Metab Disord. 2010 Mar;11(1):75-86. doi: 10.1007/s11154-010-9135-3.
9
Thyroid hormone and atherosclerosis.甲状腺激素与动脉粥样硬化。
Vascul Pharmacol. 2010 Mar-Apr;52(3-4):151-6. doi: 10.1016/j.vph.2009.09.004. Epub 2009 Oct 4.
10
Higher serum free thyroxine levels are associated with coronary artery disease.较高的血清游离甲状腺素水平与冠状动脉疾病有关。
Endocr J. 2008 Oct;55(5):819-26. doi: 10.1507/endocrj.k08e-010. Epub 2008 May 23.